vs
アボット(CLB)とCSW INDUSTRIALS, INC.(CSW)の財務データ比較。上の社名をクリックして会社を切り替えられます
CSW INDUSTRIALS, INC.の直近四半期売上が大きい($233.0M vs $121.8M、アボットの約1.9倍)。CSW INDUSTRIALS, INC.の純利益率が高く(4.4% vs 4.2%、差は0.2%)。CSW INDUSTRIALS, INC.の前年同期比売上増加率が高い(20.3% vs -1.4%)。CSW INDUSTRIALS, INC.の直近四半期フリーキャッシュフローが多い($22.7M vs $517.0K)。過去8四半期でCSW INDUSTRIALS, INC.の売上複合成長率が高い(5.1% vs -3.4%)
アボットは本社を米国イリノイ州アボットパークに置く多国籍ヘルスケア企業です。診断製品、栄養関連製品、医療機器を主力事業とし、米国国外向けに医薬品も販売しており、世界的に有名なヘルスケアプロバイダーです。
CLB vs CSW — 直接比較
売上が大きい
CSW
1.9倍大きい
$121.8M
売上成長率が高い
CSW
+21.8%の差
-1.4%
純利益率が高い
CSW
純利益率が0.2%高い
4.2%
フリーキャッシュフローが多い
CSW
FCF $22.2M多い
$517.0K
2年売上CAGRが高い
CSW
2年複合成長率
-3.4%
損益計算書 — Q1 FY2026 vs Q3 FY2026
| 指標 | ||
|---|---|---|
| 売上 | $121.8M | $233.0M |
| 純利益 | $5.1M | $10.3M |
| 粗利率 | — | 39.7% |
| 営業利益率 | 1.5% | 7.4% |
| 純利益率 | 4.2% | 4.4% |
| 売上前年比 | -1.4% | 20.3% |
| 純利益前年比 | — | -61.9% |
| EPS(希薄化後) | $0.11 | $0.62 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上
CLB
CSW
| Q1 26 | $121.8M | — | ||
| Q4 25 | $138.3M | $233.0M | ||
| Q3 25 | $134.5M | $277.0M | ||
| Q2 25 | $130.2M | $263.6M | ||
| Q1 25 | $123.6M | $230.5M | ||
| Q4 24 | $129.2M | $193.6M | ||
| Q3 24 | $134.4M | $227.9M | ||
| Q2 24 | $130.6M | $226.2M |
純利益
CLB
CSW
| Q1 26 | $5.1M | — | ||
| Q4 25 | $4.9M | $10.3M | ||
| Q3 25 | $14.2M | $40.7M | ||
| Q2 25 | $10.6M | $40.9M | ||
| Q1 25 | $-154.0K | $35.1M | ||
| Q4 24 | $7.4M | $26.9M | ||
| Q3 24 | $11.7M | $36.1M | ||
| Q2 24 | $9.0M | $38.6M |
粗利率
CLB
CSW
| Q1 26 | — | — | ||
| Q4 25 | 20.8% | 39.7% | ||
| Q3 25 | 22.0% | 43.0% | ||
| Q2 25 | 20.3% | 43.8% | ||
| Q1 25 | 19.5% | 44.2% | ||
| Q4 24 | 17.8% | 41.4% | ||
| Q3 24 | 20.5% | 45.6% | ||
| Q2 24 | 21.2% | 47.5% |
営業利益率
CLB
CSW
| Q1 26 | 1.5% | — | ||
| Q4 25 | 11.5% | 7.4% | ||
| Q3 25 | 15.6% | 20.5% | ||
| Q2 25 | 11.7% | 20.8% | ||
| Q1 25 | 3.6% | 19.5% | ||
| Q4 24 | 11.0% | 15.3% | ||
| Q3 24 | 14.7% | 22.6% | ||
| Q2 24 | 12.3% | 24.3% |
純利益率
CLB
CSW
| Q1 26 | 4.2% | — | ||
| Q4 25 | 3.6% | 4.4% | ||
| Q3 25 | 10.6% | 14.7% | ||
| Q2 25 | 8.2% | 15.5% | ||
| Q1 25 | -0.1% | 15.2% | ||
| Q4 24 | 5.7% | 13.9% | ||
| Q3 24 | 8.7% | 15.8% | ||
| Q2 24 | 6.9% | 17.1% |
EPS(希薄化後)
CLB
CSW
| Q1 26 | $0.11 | — | ||
| Q4 25 | $0.11 | $0.62 | ||
| Q3 25 | $0.30 | $2.41 | ||
| Q2 25 | $0.22 | $2.43 | ||
| Q1 25 | $0.00 | $2.05 | ||
| Q4 24 | $0.15 | $1.60 | ||
| Q3 24 | $0.25 | $2.26 | ||
| Q2 24 | $0.19 | $2.47 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $22.8M | $40.2M |
| 総負債低いほど良い | — | — |
| 株主資本純資産 | $275.1M | $1.1B |
| 総資産 | $587.7M | $2.3B |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
現金・短期投資
CLB
CSW
| Q1 26 | $22.8M | — | ||
| Q4 25 | $22.7M | $40.2M | ||
| Q3 25 | $25.6M | $31.5M | ||
| Q2 25 | $31.2M | $38.0M | ||
| Q1 25 | $22.1M | $225.8M | ||
| Q4 24 | $19.2M | $213.8M | ||
| Q3 24 | $21.5M | $273.2M | ||
| Q2 24 | $17.7M | $18.9M |
総負債
CLB
CSW
| Q1 26 | — | — | ||
| Q4 25 | $110.3M | — | ||
| Q3 25 | $114.1M | — | ||
| Q2 25 | $124.6M | — | ||
| Q1 25 | $124.4M | $800.1M | ||
| Q4 24 | $126.1M | — | ||
| Q3 24 | $139.9M | — | ||
| Q2 24 | $147.6M | — |
株主資本
CLB
CSW
| Q1 26 | $275.1M | — | ||
| Q4 25 | $266.0M | $1.1B | ||
| Q3 25 | $271.3M | $1.1B | ||
| Q2 25 | $261.3M | $1.1B | ||
| Q1 25 | $253.4M | $1.1B | ||
| Q4 24 | $246.6M | $1.0B | ||
| Q3 24 | $250.7M | $1.0B | ||
| Q2 24 | $240.3M | $650.2M |
総資産
CLB
CSW
| Q1 26 | $587.7M | — | ||
| Q4 25 | $584.0M | $2.3B | ||
| Q3 25 | $591.4M | $1.5B | ||
| Q2 25 | $602.1M | $1.5B | ||
| Q1 25 | $591.5M | $1.4B | ||
| Q4 24 | $585.1M | $1.4B | ||
| Q3 24 | $600.5M | $1.4B | ||
| Q2 24 | $597.8M | $1.1B |
負債/資本比率
CLB
CSW
| Q1 26 | — | — | ||
| Q4 25 | 0.41× | — | ||
| Q3 25 | 0.42× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | 0.49× | 0.75× | ||
| Q4 24 | 0.51× | — | ||
| Q3 24 | 0.56× | — | ||
| Q2 24 | 0.61× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $4.0M | $28.9M |
| フリーキャッシュフロー営業CF - 設備投資 | $517.0K | $22.7M |
| FCFマージンFCF / 売上 | 0.4% | 9.8% |
| 設備投資強度設備投資 / 売上 | — | 2.6% |
| キャッシュ転換率営業CF / 純利益 | 0.77× | 2.81× |
| 直近12ヶ月FCF直近4四半期 | $22.5M | $162.0M |
8四半期トレンド — 暦四半期で整列
営業キャッシュフロー
CLB
CSW
| Q1 26 | $4.0M | — | ||
| Q4 25 | $7.9M | $28.9M | ||
| Q3 25 | $8.5M | $61.8M | ||
| Q2 25 | $13.9M | $60.6M | ||
| Q1 25 | $6.7M | $27.3M | ||
| Q4 24 | $20.6M | $11.6M | ||
| Q3 24 | $13.1M | $66.8M | ||
| Q2 24 | $17.1M | $62.7M |
フリーキャッシュフロー
CLB
CSW
| Q1 26 | $517.0K | — | ||
| Q4 25 | $5.0M | $22.7M | ||
| Q3 25 | $6.5M | $58.7M | ||
| Q2 25 | $10.4M | $57.7M | ||
| Q1 25 | $3.9M | $22.8M | ||
| Q4 24 | $17.4M | $8.5M | ||
| Q3 24 | $10.4M | $61.3M | ||
| Q2 24 | $14.3M | $59.6M |
FCFマージン
CLB
CSW
| Q1 26 | 0.4% | — | ||
| Q4 25 | 3.6% | 9.8% | ||
| Q3 25 | 4.8% | 21.2% | ||
| Q2 25 | 8.0% | 21.9% | ||
| Q1 25 | 3.1% | 9.9% | ||
| Q4 24 | 13.4% | 4.4% | ||
| Q3 24 | 7.7% | 26.9% | ||
| Q2 24 | 10.9% | 26.3% |
設備投資強度
CLB
CSW
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | 2.6% | ||
| Q3 25 | 1.5% | 1.1% | ||
| Q2 25 | 2.7% | 1.1% | ||
| Q1 25 | 2.3% | 2.0% | ||
| Q4 24 | 2.5% | 1.6% | ||
| Q3 24 | 2.0% | 2.4% | ||
| Q2 24 | 2.2% | 1.4% |
キャッシュ転換率
CLB
CSW
| Q1 26 | 0.77× | — | ||
| Q4 25 | 1.61× | 2.81× | ||
| Q3 25 | 0.60× | 1.52× | ||
| Q2 25 | 1.31× | 1.48× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 2.78× | 0.43× | ||
| Q3 24 | 1.12× | 1.85× | ||
| Q2 24 | 1.90× | 1.62× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CLB
セグメントデータなし
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |